Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

1.

Polymer multilayer tattooing for enhanced DNA vaccination.

DeMuth PC, Min Y, Huang B, Kramer JA, Miller AD, Barouch DH, Hammond PT, Irvine DJ.

Nat Mater. 2013 Apr;12(4):367-76. doi: 10.1038/nmat3550. Epub 2013 Jan 27.

2.

Polyplex-releasing microneedles for enhanced cutaneous delivery of DNA vaccine.

Kim NW, Lee MS, Kim KR, Lee JE, Lee K, Park JS, Matsumoto Y, Jo DG, Lee H, Lee DS, Jeong JH.

J Control Release. 2014 Apr 10;179:11-7. doi: 10.1016/j.jconrel.2014.01.016. Epub 2014 Jan 23.

PMID:
24462900
3.

Releasable layer-by-layer assembly of stabilized lipid nanocapsules on microneedles for enhanced transcutaneous vaccine delivery.

DeMuth PC, Moon JJ, Suh H, Hammond PT, Irvine DJ.

ACS Nano. 2012 Sep 25;6(9):8041-51. Epub 2012 Aug 30.

4.

Comparison of intradermal and intramuscular delivery followed by in vivo electroporation of SIV Env DNA in macaques.

Kulkarni V, Rosati M, Bear J, Pilkington GR, Jalah R, Bergamaschi C, Singh AK, Alicea C, Chowdhury B, Zhang GM, Kim EY, Wolinsky SM, Huang W, Guan Y, LaBranche C, Montefiori DC, Broderick KE, Sardesai NY, Valentin A, Felber BK, Pavlakis GN.

Hum Vaccin Immunother. 2013 Oct;9(10):2081-94. doi: 10.4161/hv.25473. Epub 2013 Jun 28.

5.

Electroporation as a "prime/boost" strategy for naked DNA vaccination against a tumor antigen.

Buchan S, Grønevik E, Mathiesen I, King CA, Stevenson FK, Rice J.

J Immunol. 2005 May 15;174(10):6292-8.

6.

Electroporation mediated DNA vaccination directly to a mucosal surface results in improved immune responses.

Kichaev G, Mendoza JM, Amante D, Smith TR, McCoy JR, Sardesai NY, Broderick KE.

Hum Vaccin Immunother. 2013 Oct;9(10):2041-8. doi: 10.4161/hv.25272. Epub 2013 Jun 11.

7.

Optimization of intradermal vaccination by DNA tattooing in human skin.

van den Berg JH, Nujien B, Beijnen JH, Vincent A, van Tinteren H, Kluge J, Woerdeman LA, Hennink WE, Storm G, Schumacher TN, Haanen JB.

Hum Gene Ther. 2009 Mar;20(3):181-9. doi: 10.1089/hgt.2008.073.

8.

Enhanced immunogenicity of an HIV-1 DNA vaccine delivered with electroporation via combined intramuscular and intradermal routes.

Mann JF, McKay PF, Fiserova A, Klein K, Cope A, Rogers P, Swales J, Seaman MS, Combadiere B, Shattock RJ.

J Virol. 2014 Jun;88(12):6959-69. doi: 10.1128/JVI.00183-14. Epub 2014 Apr 9.

9.

Microneedle-based vaccines.

Prausnitz MR, Mikszta JA, Cormier M, Andrianov AK.

Curr Top Microbiol Immunol. 2009;333:369-93. doi: 10.1007/978-3-540-92165-3_18. Review.

10.

Intradermal DNA vaccination enhanced by low-current electroporation improves antigen expression and induces robust cellular and humoral immune responses.

Hutnick NA, Myles DJ, Ferraro B, Lucke C, Lin F, Yan J, Broderick KE, Khan AS, Sardesai NY, Weiner DB.

Hum Gene Ther. 2012 Sep;23(9):943-50. doi: 10.1089/hum.2012.055. Epub 2012 Aug 2.

11.

DNA vaccination in skin enhanced by electroporation.

Broderick KE, Khan AS, Sardesai NY.

Methods Mol Biol. 2014;1143:123-30. doi: 10.1007/978-1-4939-0410-5_8.

PMID:
24715285
12.

Biodistribution, persistence and lack of integration of a multigene HIV vaccine delivered by needle-free intradermal injection and electroporation.

Bråve A, Gudmundsdotter L, Sandström E, Haller BK, Hallengärd D, Maltais AK, King AD, Stout RR, Blomberg P, Höglund U, Hejdeman B, Biberfeld G, Wahren B.

Vaccine. 2010 Nov 29;28(51):8203-9. doi: 10.1016/j.vaccine.2010.08.108. Epub 2010 Oct 15.

PMID:
20951666
13.

DNA tattoo vaccination: effect on plasmid purity and transfection efficiency of different topoisoforms.

Quaak SG, van den Berg JH, Oosterhuis K, Beijnen JH, Haanen JB, Nuijen B.

J Control Release. 2009 Oct 15;139(2):153-9. doi: 10.1016/j.jconrel.2009.06.033. Epub 2009 Jul 4.

PMID:
19580829
14.

Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine.

Kanagavelu SK, Snarsky V, Termini JM, Gupta S, Barzee S, Wright JA, Khan WN, Kornbluth RS, Stone GW.

Vaccine. 2012 Jan 17;30(4):691-702. doi: 10.1016/j.vaccine.2011.11.088. Epub 2011 Dec 4.

15.
16.

Optimization of electroporation-enhanced intradermal delivery of DNA vaccine using a minimally invasive surface device.

Lin F, Shen X, Kichaev G, Mendoza JM, Yang M, Armendi P, Yan J, Kobinger GP, Bello A, Khan AS, Broderick KE, Sardesai NY.

Hum Gene Ther Methods. 2012 Jun;23(3):157-68. doi: 10.1089/hgtb.2011.209. Epub 2012 Jul 13.

17.

DNA vaccines and intradermal vaccination by DNA tattooing.

Oosterhuis K, van den Berg JH, Schumacher TN, Haanen JB.

Curr Top Microbiol Immunol. 2012;351:221-50. doi: 10.1007/82_2010_117. Review.

PMID:
21107792
18.

Late administration of plasmid DNA by intradermal electroporation efficiently boosts DNA-primed T and B cell responses to carcinoembryonic antigen.

Bråve A, Hallengärd D, Gudmundsdotter L, Stout R, Walters R, Wahren B, Hallermalm K.

Vaccine. 2009 Jun 8;27(28):3692-6. doi: 10.1016/j.vaccine.2009.04.013. Epub 2009 May 3.

PMID:
19428161
19.

Injection site-dependent induction of immune response by DNA vaccine: comparison of skin and spleen as a target for vaccination.

Guan X, Nishikawa M, Takemoto S, Ohno Y, Yata T, Takakura Y.

J Gene Med. 2010 Mar;12(3):301-9. doi: 10.1002/jgm.1432.

PMID:
20084616
20.

DNA vaccination in the skin using microneedles improves protection against influenza.

Song JM, Kim YC, O E, Compans RW, Prausnitz MR, Kang SM.

Mol Ther. 2012 Jul;20(7):1472-80. doi: 10.1038/mt.2012.69. Epub 2012 Apr 17.

Supplemental Content

Support Center